Cargando…
Tuberculosis Treatment in Patients with Comorbidities
Tuberculosis is a significant infectious problem in elderly patients with comorbidities in Korea. The age-associated diseases such as malignancy and diabetes mellitus may increase the risk of tuberculosis in this population. The medication treatments of tuberculosis in patients with comorbidities ca...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092156/ https://www.ncbi.nlm.nih.gov/pubmed/25024718 http://dx.doi.org/10.4046/trd.2014.76.6.257 |
| _version_ | 1782325457247535104 |
|---|---|
| author | Kang, Young Ae |
| author_facet | Kang, Young Ae |
| author_sort | Kang, Young Ae |
| collection | PubMed |
| description | Tuberculosis is a significant infectious problem in elderly patients with comorbidities in Korea. The age-associated diseases such as malignancy and diabetes mellitus may increase the risk of tuberculosis in this population. The medication treatments of tuberculosis in patients with comorbidities can cause adverse reactions to antituberculosis drugs and inadequate treatment responses. Thus, clinicians must carefully monitor the toxicity of antituberculosis therapy and the efficacy of treatment in patients with comorbidities. |
| format | Online Article Text |
| id | pubmed-4092156 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | The Korean Academy of Tuberculosis and Respiratory Diseases |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-40921562014-07-14 Tuberculosis Treatment in Patients with Comorbidities Kang, Young Ae Tuberc Respir Dis (Seoul) Review Tuberculosis is a significant infectious problem in elderly patients with comorbidities in Korea. The age-associated diseases such as malignancy and diabetes mellitus may increase the risk of tuberculosis in this population. The medication treatments of tuberculosis in patients with comorbidities can cause adverse reactions to antituberculosis drugs and inadequate treatment responses. Thus, clinicians must carefully monitor the toxicity of antituberculosis therapy and the efficacy of treatment in patients with comorbidities. The Korean Academy of Tuberculosis and Respiratory Diseases 2014-06 2014-06-28 /pmc/articles/PMC4092156/ /pubmed/25024718 http://dx.doi.org/10.4046/trd.2014.76.6.257 Text en Copyright©2014. The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved. http://creativecommons.org/licenses/by-nc/3.0/ It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) |
| spellingShingle | Review Kang, Young Ae Tuberculosis Treatment in Patients with Comorbidities |
| title | Tuberculosis Treatment in Patients with Comorbidities |
| title_full | Tuberculosis Treatment in Patients with Comorbidities |
| title_fullStr | Tuberculosis Treatment in Patients with Comorbidities |
| title_full_unstemmed | Tuberculosis Treatment in Patients with Comorbidities |
| title_short | Tuberculosis Treatment in Patients with Comorbidities |
| title_sort | tuberculosis treatment in patients with comorbidities |
| topic | Review |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092156/ https://www.ncbi.nlm.nih.gov/pubmed/25024718 http://dx.doi.org/10.4046/trd.2014.76.6.257 |
| work_keys_str_mv | AT kangyoungae tuberculosistreatmentinpatientswithcomorbidities |